Recent progress in antitumoral synthetic vaccines.

Abstract

Antitumoral synthetic vaccines offer a promising alternative to overcome problems associated with traditional treatments. Numerous vaccine prototypes have been described in the last two decades; however, none of them have been revealed satisfactory in clinical trials due to side effects, low bioavailability, uncertain molecular composition, and/or… (More)
DOI: 10.1021/ml5003794

Topics

  • Presentations referencing similar topics